Thyroid autoantibodies and thyroid function in patients with pancreatic adenocarcinoma

Acta Oncologica

Volumn 36, Issue 1, 1997, Pages 65-68

  Fyssas, Ioannis ^a   Syrigos, Konstantinos N ^a,b   Konstantoulakis, Manousos M ^a   Tsibloulis, Vassilios ^a   Manouras, Andreas ^a   Peveretos, Panayotis ^a   Golematis, Basilios C ^a  

^a HIPPOKRATION HOSPITAL   (Greece)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

THYROID ANTIBODY;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOREGULATION; MALE; PANCREAS CARCINOMA; PRIORITY JOURNAL; THYROID FUNCTION;

EID: 0030936003     PISSN: 0284186X     EISSN: None     Source Type: Journal    
DOI: 10.3109/02841869709100735     Document Type: Article

References (31)

1. Nix GA, Schmitz PJ, Wilson JHP. Carcinoma of the head of the pancreas. Therapeutic implications of endoscopic retrograde pancreatography. Gastroenlerology 1984; 87: 37-43.
2. Di Magno EP, Eugene P. Early diagnosis of chronic pancreatitis and pancreatic cancer. Med Clin North Am 1988; 72: 979-92.
3. Baylin SB, Mendelsohn GH. Ectopic (inappropriate) hormone production by tumours: Mechanisms involved and the biological and clinical implications. Endocr Rev 1980; 1: 45-8.
4. Theofilopoulos AN . Immune complexes in cancer. N Engl J Med 1982; 302: 1208-9.
5. Kostiala AA, Gripenberg M, Eloren E, et al. Follow-up of antibodies against single stranded DNA in patients with haematological malignancies. Clin Exp Immunol 1985; 61: 15-23.
6. Cancer of the Pancreas Task Force. Staging of cancer of the pancreas. Cancer 1981; 47: 163-9.
7. Hermanek P, Sobin LH. UICC, TNM classification of malignant tumours. Berlin; Springer-Verlag, 1987: 65-7.
8. Kloppel G, Maillet B. Classification and staging of pancreatic nonendocrine tumours. Radiol Clin North Am 1989; 27: 105-12.
9. Syrigos KN, Konstantoulakis MM, Constantoulakis M, et al: Thyroid autoantibodies and thyroid function in patients with gastric cancer. Acta Oncol 1994; 33: 905-7.
10. Konstantoulakis MM, Syrigos KN, Albanopoulos K, et al. The presence of anti-CEA antibodies in the sera of patients with Gastrointestinal Malignancies. J Clin Immunol 1994; 14: 310-13.
11. Swissa M, Cohen Y, Shoenfeld Y. Autoantibodies in the serum of patients with lymphoma. Leukem Lymphoma 1992; 7: 117-22.
12. Talal, Bunin JJ. Development of malignant lymphoma in the course of Sjogren's syndrome. Am J Med 1969; 36: 529-40.
13. Lindholm L, Holmgren J, Svennerholm L, et al. Monoclonal antibodies against gastrointestinal tumour-associated antigens isolated as monosialogangliosides. Int Arch Allergy Appl Immunol 1983; 71: 178-81.
14. Youinou P, Zabbe C, Eveillaud C, et al. Antiperinuclear activity in lung carcinoma patients. Cancer Immunol. Immunother. 1984; 18: 80-1.
15. Syrigos KN, Konstantoulakis MM, Fyssas I, et al. Autoantibodies against insulin and b-islet cells in pancreatic adenocarcinoma: a possible explanation for diabetes mellitus. Int J Cancer 1996; 61: 624-6.
16. Yamashita N, Maruchi N, Mori W. Hashimoto's thyroiditis: a possible risk factor for lung cancer among Japanese wemen. Cancer 1979; 7: 9-13.
17. Charalampopoulos A, Syrigos KN, Sagana E, et al. Thyroid autoantibodies and thyroid function in the serum of patients with colon adenocarcinoma. XVI Eur Cong Allergol Clin Immunol 1995; 2: 1001-5.
18. Rasmusson B, Feldt-Rasmusson V, Hegedusa-Perrild H, et al: Thyroid function in patient with breast cancer. Eur J Cancer 1987; 23: 553-6.
19. Goldman MB, Monson RR, Maloof F. Cancer mortality in women with thyroid disease. Cancer Res 1990; 50: 2283-9.
20. Bottuzo GF, Pajol-Borrell R, Hanafusa T, et al. Role of aberrant HLA-DR expressions and antigen presentation in induction of endocrine autoimmunity. Lancet 1983; 2: 1113-38.
21. Huminer D, Tomer Y, Pitlick S, et al. Autoantibodies in cancer patients; Are they tumour related or age related? Autoimmunity 1990; 5: 232-3.
22. Kitano N, Taminato T, Seno M, et al. Effect of antithyroid autoantibodies on pancreatic islet-cell function. Acta Diabetol 1987; 24: 9-15.
23. Adami HO, McLaughlin S, Ekban A. Cancer risk in patients with diabetes mellitus. Cancer Causes Control 1991; 2: 307-14.
24. Kohno Y, Naito N, Saito K, et al. Anti-thyroid antibody activity in sera of patients with systemic lupus erythematosus. Clin Exp Immunol 1989; 75: 217-21.
25. Salazar Paramo M, Garcia dela Torre I, Hernandez-Vasquez L, et al. Evidence of a new antigen-antibody system (anti-MIC-1) in patients with SLE and hyperthyroidism. J Rheumatol 1989; 16: 175-80.
26. Itoh K, Maruchi N. Breast cancer in patients with Hashimoto's thyroiditis. Lancet 1975; 2: 1119-21.
27. Adamopoulos DA, Vassilaros S, Kapolla N, et al. Thyroid disease in patients with benign and malignant mastopathy. Cancer 1986; 57: 125-8.
28. Rose DP, Davis TE. Plasma thyronine levels in carcinoma of the breast and colon. Arch Intern Med 1981; 141: 1161-4.
29. Haines AP, Moss AR, Whittemore A, et al. A case-control study of pancreatic carcinoma. J Cancer Res Clin Oncol 1982; 103: 93-7.
30. Bech K, Bliddal H, Feldt-Rassmussen U, et al. Heterogeneity of autoimmune thyroiditis. Allergy 1984; 39: 239-47.
31. Stott D, McLearie J, Neilson L. Analysis of the clonal origins of autoantibodies against thyroglobulin and DNA in autoimmune thyroiditis and SLE. Clin Exp Immunol 1986; 65: 520-3.